John Strony
About
John Strony is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Internal Medicine.
According to data from OpenAlex, John Strony has authored 104 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Surgery, 49 papers in Cardiology and Cardiovascular Medicine and 13 papers in Internal Medicine. Recurrent topics in John Strony's work include Acute Myocardial Infarction Research (30 papers), Antiplatelet Therapy and Cardiovascular Diseases (29 papers) and Coronary Interventions and Diagnostics (16 papers). John Strony is often cited by papers focused on Acute Myocardial Infarction Research (30 papers), Antiplatelet Therapy and Cardiovascular Diseases (29 papers) and Coronary Interventions and Diagnostics (16 papers). John Strony collaborates with scholars based in United States, Canada and Belgium. John Strony's co-authors include Enrico P. Veltri, Burt Adelman, J. Michael Sprafka, Yang Wang, Connie L. Manske, Leslie Lipka, Robert A. Harrington, Eugene Braunwald, Frans Van de Werf and Dominik Brands and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.
In The Last Decade
John Strony
96 papers receiving 4.2k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| John Strony United States | 27 | 2.7k | 2.0k | 919 | 742 | 419 | 104 | 4.4k | ||
| Lech Poloński Poland | 35 | 4.1k 1.5× | 1.4k 0.7× | 207 0.2× | 1.2k 1.6× | 798 1.9× | 263 | 5.9k | ||
| David J. Moliterno United States | 32 | 2.5k 0.9× | 1.1k 0.6× | 630 0.7× | 365 0.5× | 468 1.1× | 100 | 3.4k | ||
| Eli I. Lev Israel | 32 | 2.6k 1.0× | 1.3k 0.6× | 759 0.8× | 460 0.6× | 495 1.2× | 166 | 3.8k | ||
| Vanessa Roldán Spain | 40 | 3.6k 1.3× | 523 0.3× | 1.5k 1.6× | 637 0.9× | 290 0.7× | 226 | 5.3k | ||
| Ulrich Tebbe Germany | 32 | 4.3k 1.6× | 1.9k 0.9× | 1.4k 1.5× | 271 0.4× | 1.2k 2.8× | 202 | 5.6k | ||
| Peter Sinnaeve Belgium | 33 | 3.2k 1.2× | 1.2k 0.6× | 1.1k 1.2× | 150 0.2× | 564 1.3× | 174 | 4.8k | ||
| Jacek Musiał Poland | 37 | 962 0.4× | 1.1k 0.5× | 493 0.5× | 1.3k 1.7× | 514 1.2× | 225 | 5.0k | ||
| E. Magnus Ohman United States | 26 | 3.4k 1.3× | 2.1k 1.0× | 1.7k 1.9× | 602 0.8× | 747 1.8× | 61 | 4.9k | ||
| Laurent Bonello France | 34 | 3.6k 1.4× | 2.1k 1.0× | 904 1.0× | 265 0.4× | 452 1.1× | 187 | 4.6k | ||
| François Schiele France | 39 | 4.4k 1.7× | 3.8k 1.8× | 875 1.0× | 167 0.2× | 1.5k 3.7× | 226 | 6.8k |
Countries citing papers authored by John Strony
Since
Specialization
Citations
This map shows the geographic impact of John Strony's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Strony with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Strony more than expected).
Fields of papers citing papers by John Strony
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by John Strony. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Strony. The network helps show where John Strony may publish in the future.
Co-authorship network of co-authors of John Strony
This figure shows the co-authorship network connecting the top 25 collaborators of John Strony. A scholar is included among the top collaborators of John Strony based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Strony. John Strony is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Strony, John, et al.. (2026). Serotonergic antidepressants are associated with increased bleeding events within 30-days after total shoulder arthroplasty: a propensity-matched analysis of 54,291 patients. Archives of Orthopaedic and Trauma Surgery. 146(1).
2.
Piper, Molly, et al.. (2025). Local Subcutaneous Fat Depth Is Associated With Increased Complications After Total Shoulder Arthroplasty. Journal of the American Academy of Orthopaedic Surgeons. 33(14). 787–792.
3.
Strony, John, et al.. (2024). The effect of high-normal preoperative international normalized ratios on postoperative outcomes and complications following posterior cervical spine surgery. Journal of Orthopaedic Surgery and Research. 19(1). 552–552.
4.
Adelstein, Jeremy M., et al.. (2024). Serotonergic Antidepressants Are Associated With Higher Rates of Hematoma After Anterior Cervical Spine Surgery. Spine. 50(7). 477–484.
5.
Fram, Brianna, John Strony, Raymond Chen, Surena Namdari, & James C. Krieg. (2023). Proximal humerus fractures: Postoperative protocols and factors affecting treatment decisions among shoulder and elbow and orthopedic trauma surgeons. Journal of Orthopaedics. 49. 75–80.
6.
Raji, Yazdan, John Strony, Nikunj N. Trivedi, et al.. (2021). Effects of opioid-limiting legislation on postoperative opioid use in shoulder arthroplasty in an epidemic epicenter. Journal of Shoulder and Elbow Surgery. 31(2). 269–275.
7.
Strony, John, et al.. (2021). Distal Femoral Replacement and Periprosthetic Joint Infection After Non-Oncological Reconstruction: A Retrospective Analysis. The Journal of Arthroplasty. 36(12). 3959–3965.
8.
Grisanti, Laurel A., Claudio de Lucia, Toby P. Thomas, et al.. (2019). Prior beta blocker treatment decreases leukocyte responsiveness to injury. JCI Insight. 4(9).
9.
Strony, John, Scot Brown, Peter Choong, et al.. (2019). Musculoskeletal Infection in Orthopaedic Oncology. Journal of Bone and Joint Surgery. 101(20). e107–e107.
10.
Weitz, Jeffrey I., Gary E. Raskob, Michael R. Lassen, et al.. (2019). COMPARISON OF JNJ9375, A THROMBIN EXOSITE 1-DIRECTED ANTIBODY, WITH APIXABAN FOR THROMBOPROPHYLAXIS AFTER ELECTIVE KNEE REPLACEMENT SURGERY: TEXT-TKR STUDY. Journal of the American College of Cardiology. 73(9). 2047–2047.
11.
Galetta, Matthew S., Heeren Makanji, John Strony, Dhruv K.C. Goyal, & Mark F. Kurd. (2019). Changing reimbursement models and private equity ownership in spine surgery. Annals of Translational Medicine. 7(S5). S166–S166.
12.
Bagai, Akshay, Zhen Huang, Yuliya Lokhnygina, et al.. (2015). Magnitude of Troponin Elevation and Long-Term Clinical Outcomes in Acute Coronary Syndrome Patients Treated With and Without Revascularization. Circulation Cardiovascular Interventions. 8(6). e002314–e002314.
13.
Valgimigli, Marco, Pierluigi Tricoci, Zhen Huang, et al.. (2014). Usefulness and Safety of Vorapaxar in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention (from the TRACER Trial). The American Journal of Cardiology. 114(5). 665–673.
14.
Jones, Schuyler, Pierluigi Tricoci, Zhen Huang, et al.. (2013). Abstract 17939: Vorapaxar in Non-ST-Segment Elevation Acute Coronary Syndrome Patients With Peripheral Artery Disease: Results From TRACER. Circulation.
15.
Jones, Schuyler, Pierluigi Tricoci, Zhen Huang, et al.. (2013). Vorapaxar in Non-ST-Segment Elevation Acute Coronary Syndrome Patients With Peripheral Artery Disease : Results From TRACER. Circulation. 128(22).
16.
Armaganijan, Luciana, Renato D. Lópes, Zhen Huang, et al.. (2013). Efficacy and Safety of Vorapaxar in Elderly Patients With Non-ST-Segment Elevation Acute Coronary Syndrome : Insights From the TRACER Trial. Circulation. 128(22).
17.
Roe, Matthew T., Robert P. Giugliano, Robert A. Harrington, et al.. (2001). Combination Reperfusion Therapy with Eptifibatide and Tenecteplase for Acute Myocardial Infarction. 1(1). 5–13.
18.
Piana, Robert N., Waqar Ahmed, Bernard Chaitman, et al.. (1999). Effect of transient abrupt vessel closure during otherwise successful angioplasty for unstable angina on clinical outcome at six months. Journal of the American College of Cardiology. 33(1). 73–78.
19.
Bittl, John A., Mark W. Wolfe, Gary S. Roubin, et al.. (1995). 1017-74 Length of Hospital Stay After Percutaneous Transluminal Coronary Angioplasty: Clinical and Angiographic Predictors. Journal of the American College of Cardiology. 25(2). 392A–392A.
20.
Strony, John, John A. Bittl, Ezra Deutsch, et al.. (1995). 1006-43 Hirulog™ vs. Heparin During Percutaneous Transluminal Coronary Angioplasty in Patients with Post-Infarction Angina: Results of the Myocardial Infarction Arm of the Hirulog Angioplasty Trial. Journal of the American College of Cardiology. 25(2). 357A–357A.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Lech Poloński Breakdown of academic impact, for papers by David J. Moliterno Breakdown of academic impact, for papers by Eli I. Lev Breakdown of academic impact, for papers by Vanessa Roldán Breakdown of academic impact, for papers by Ulrich Tebbe Breakdown of academic impact, for papers by Peter Sinnaeve Breakdown of academic impact, for papers by Jacek Musiał Breakdown of academic impact, for papers by E. Magnus Ohman Breakdown of academic impact, for papers by Laurent Bonello Breakdown of academic impact, for papers by François Schiele